vs
Side-by-side financial comparison of PAMT CORP (PAMT) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $141.3M, roughly 1.2× PAMT CORP). PAMT CORP runs the higher net margin — -20.7% vs -82.0%, a 61.3% gap on every dollar of revenue. On growth, PAMT CORP posted the faster year-over-year revenue change (-15.1% vs -22.7%). PAMT CORP produced more free cash flow last quarter ($-25.0M vs $-36.6M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -12.0%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PAMT vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $141.3M | $164.7M |
| Net Profit | $-29.3M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -27.0% | -43.3% |
| Net Margin | -20.7% | -82.0% |
| Revenue YoY | -15.1% | -22.7% |
| Net Profit YoY | 7.4% | -104.8% |
| EPS (diluted) | $-1.38 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $141.3M | $164.7M | ||
| Q3 25 | $150.3M | $211.0M | ||
| Q2 25 | $151.1M | $178.9M | ||
| Q1 25 | $155.3M | $1.2B | ||
| Q4 24 | $166.5M | $213.2M | ||
| Q3 24 | $182.6M | $196.8M | ||
| Q2 24 | $182.9M | $186.7M | ||
| Q1 24 | $182.6M | $210.1M |
| Q4 25 | $-29.3M | $-135.0M | ||
| Q3 25 | $-5.6M | $15.9M | ||
| Q2 25 | $-9.6M | $-64.8M | ||
| Q1 25 | $-8.1M | $866.6M | ||
| Q4 24 | $-31.6M | $-65.9M | ||
| Q3 24 | $2.4M | $-106.7M | ||
| Q2 24 | $-2.9M | $-99.2M | ||
| Q1 24 | $281.0K | $-91.6M |
| Q4 25 | -27.0% | -43.3% | ||
| Q3 25 | -3.8% | 1.4% | ||
| Q2 25 | -7.3% | -19.5% | ||
| Q1 25 | -5.9% | 82.5% | ||
| Q4 24 | -22.6% | -76.2% | ||
| Q3 24 | 1.3% | -27.7% | ||
| Q2 24 | -0.4% | -21.5% | ||
| Q1 24 | -0.4% | -21.6% |
| Q4 25 | -20.7% | -82.0% | ||
| Q3 25 | -3.7% | 7.5% | ||
| Q2 25 | -6.4% | -36.3% | ||
| Q1 25 | -5.2% | 73.7% | ||
| Q4 24 | -19.0% | -30.9% | ||
| Q3 24 | 1.3% | -54.2% | ||
| Q2 24 | -1.6% | -53.1% | ||
| Q1 24 | 0.2% | -43.6% |
| Q4 25 | $-1.38 | $-1.63 | ||
| Q3 25 | $-0.27 | $0.20 | ||
| Q2 25 | $-0.46 | $-0.83 | ||
| Q1 25 | $-0.37 | $10.04 | ||
| Q4 24 | $-1.44 | $-0.85 | ||
| Q3 24 | $0.11 | $-1.39 | ||
| Q2 24 | $-0.13 | $-1.29 | ||
| Q1 24 | $0.01 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.7M | $1.9B |
| Total DebtLower is stronger | $333.9M | — |
| Stockholders' EquityBook value | $210.5M | $-205.3M |
| Total Assets | $697.9M | $2.9B |
| Debt / EquityLower = less leverage | 1.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.7M | $1.9B | ||
| Q3 25 | $115.6M | $1.7B | ||
| Q2 25 | $117.3M | $2.0B | ||
| Q1 25 | $102.7M | $2.0B | ||
| Q4 24 | $110.7M | $1.1B | ||
| Q3 24 | $92.3M | $1.0B | ||
| Q2 24 | $114.0M | $1.1B | ||
| Q1 24 | $125.8M | $884.8M |
| Q4 25 | $333.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $325.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $210.5M | $-205.3M | ||
| Q3 25 | $239.5M | $-155.8M | ||
| Q2 25 | $244.9M | $-206.5M | ||
| Q1 25 | $269.6M | $-185.8M | ||
| Q4 24 | $277.5M | $-1.1B | ||
| Q3 24 | $308.9M | $-1.1B | ||
| Q2 24 | $306.7M | $-980.2M | ||
| Q1 24 | $314.6M | $-893.9M |
| Q4 25 | $697.9M | $2.9B | ||
| Q3 25 | $715.2M | $2.6B | ||
| Q2 25 | $707.9M | $2.6B | ||
| Q1 25 | $712.6M | $2.7B | ||
| Q4 24 | $741.7M | $1.7B | ||
| Q3 24 | $756.7M | $1.8B | ||
| Q2 24 | $733.5M | $1.9B | ||
| Q1 24 | $746.4M | $1.8B |
| Q4 25 | 1.59× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.17× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $-25.0M | $-36.6M |
| FCF MarginFCF / Revenue | -17.7% | -22.3% |
| Capex IntensityCapex / Revenue | 13.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-23.4M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.8M | $-34.3M | ||
| Q3 25 | $5.9M | $-66.3M | ||
| Q2 25 | $12.2M | $-58.3M | ||
| Q1 25 | $5.0M | $870.1M | ||
| Q4 24 | $15.2M | $-30.0M | ||
| Q3 24 | $15.5M | $-77.0M | ||
| Q2 24 | $18.7M | $-71.5M | ||
| Q1 24 | $9.6M | $70.8M |
| Q4 25 | $-25.0M | $-36.6M | ||
| Q3 25 | $2.5M | $-69.7M | ||
| Q2 25 | $5.9M | $-59.6M | ||
| Q1 25 | $-6.8M | $868.4M | ||
| Q4 24 | $-39.9M | $-33.8M | ||
| Q3 24 | $-33.6M | $-77.5M | ||
| Q2 24 | $4.1M | $-78.8M | ||
| Q1 24 | $-12.2M | $61.2M |
| Q4 25 | -17.7% | -22.3% | ||
| Q3 25 | 1.7% | -33.1% | ||
| Q2 25 | 3.9% | -33.3% | ||
| Q1 25 | -4.4% | 73.8% | ||
| Q4 24 | -24.0% | -15.8% | ||
| Q3 24 | -18.4% | -39.4% | ||
| Q2 24 | 2.2% | -42.2% | ||
| Q1 24 | -6.7% | 29.1% |
| Q4 25 | 13.6% | 1.4% | ||
| Q3 25 | 2.3% | 1.6% | ||
| Q2 25 | 4.2% | 0.7% | ||
| Q1 25 | 7.6% | 0.1% | ||
| Q4 24 | 33.1% | 1.8% | ||
| Q3 24 | 26.9% | 0.3% | ||
| Q2 24 | 8.0% | 4.0% | ||
| Q1 24 | 12.0% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.44× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 34.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PAMT
| Freight Transportation Service | $123.1M | 87% |
| Fuel Surcharge | $18.2M | 13% |
PTCT
Segment breakdown not available.
